These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4100946)

  • 21. [ANTICOMPLEMENT EFFECTS OF SERUM AND GAMMA-GLOBULIN].
    SCHIERZ G
    Z Immunitats Allergieforsch; 1964 Oct; 127():418-27. PubMed ID: 14323406
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunologic properties, aggregate content and half-life of various human i.v. gamma globulin preparations].
    Ring J; Duswald KH; Seifert J; Brendel W
    Langenbecks Arch Chir; 1976; Suppl():63-7. PubMed ID: 73997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of commercial Coombs reagents and their anti-complement activity.
    Bowlen VJ
    Am J Med Technol; 1972 Oct; 38(10):381-6. PubMed ID: 4117024
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lyophilized anti-D gamma globulin given intravenously for the prevention of anti-Rh immunization].
    Jouvenceaux A; Adenot N; Berthoux F; Revol L
    Rev Fr Transfus; 1969; 12(1):Suppl:341-7. PubMed ID: 4193519
    [No Abstract]   [Full Text] [Related]  

  • 25. [Longterm therapy with i.v.-gamma-globulin in children (author's transl)].
    Kornhuber B
    Monatsschr Kinderheilkd (1902); 1979 Jan; 127(1):20-2. PubMed ID: 83534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The anticomplementarity of gamma-globulin preparations].
    Ternovoĭ AP; Strigin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):136-7. PubMed ID: 4141554
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW; Takahashi M; Burns JC; Beiser AS; Chung KJ; Duffy CE; Glode MP; Mason WH; Reddy V; Sanders SP
    N Engl J Med; 1986 Aug; 315(6):341-7. PubMed ID: 2426590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous gamma-globulin: clinical applications in pediatric care.
    Ott MJ; Senner A; Esker S; Knapp R; Bolinger AM
    J Pediatr Nurs; 1990 Oct; 5(5):307-15. PubMed ID: 1698963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HTLV-III/LAV antibodies in gamma globulin preparations for intravenous use].
    Kaeser A
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1263. PubMed ID: 2427300
    [No Abstract]   [Full Text] [Related]  

  • 30. Protection of nonimmune volunteers against rubella by intravenous administration of normal human gamma globulin.
    Martin du Pan R; Koechli B; Douath A
    J Infect Dis; 1972 Sep; 126(3):341-4. PubMed ID: 4115429
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous gammaglobulin for reaction to intramuscular preparation.
    Peerless AG; Stiehm ER
    Lancet; 1983 Aug; 2(8347):461. PubMed ID: 6192306
    [No Abstract]   [Full Text] [Related]  

  • 32. One-day intravenous therapy with high-dose gamma-globulin for idiopathic thrombocytopenic purpura.
    Sasaki A; Furukawa Y; Inoue T; Yamane T; Sannomiya Y; Im T; Tatsumi N
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):147-9. PubMed ID: 2472726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous gamma globulin therapy.
    Good RA
    J Clin Immunol; 1982 Apr; 2(2 Suppl):48S. PubMed ID: 6177710
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in immunoglobulin preparations for intravenous use: a comparison of six products.
    Greenbaum BH
    Am J Pediatr Hematol Oncol; 1990; 12(4):490-6. PubMed ID: 1704686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous administration of modified gamma globulin. Several studies on a patient with agammaglobulinemia.
    Jager BV
    Arch Intern Med; 1967 Jan; 119(1):60-4. PubMed ID: 4163002
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-A, non-B hepatitis after intravenous gammaglobulin.
    Lancet; 1986 Feb; 1(8476):322-3. PubMed ID: 2418320
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of intravenous gamma globulin in malignant hematologic diseases].
    Garay GE
    Medicina (B Aires); 1989; 49(6):621-7. PubMed ID: 2484842
    [No Abstract]   [Full Text] [Related]  

  • 38. [The safety of treatment with intravenous gamma-globulin in patients with primary hypogammaglobulinemias].
    Sierra FJ; Gil A; Lavilla P; Martín JC
    Med Clin (Barc); 1995 Nov; 105(16):636. PubMed ID: 8523946
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies with intravenous gamma globulin.
    Merler E; Rosen FS; Salmon S; Crain JD; Janeway CA
    Vox Sang; 1967 Jul; 13(1):102-3. PubMed ID: 4166586
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation of Non-modified gamma globulin for intravenous use.
    Schneider W; Wolter D; McCarty LJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):938-45. PubMed ID: 64437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.